SUBSCRIBE
SUBSCRIBE
News   Deals

Sanofi-Aventis (France) to Buy Dyax Corp.'s (JOBS) Drug Development Partner, Fovea Pharmaceuticals

October 13, 2009 | 
1 min read
Bookmark and Share

Reuters -- French drugmaker Sanofi-Aventis agreed to acquire Fovea Pharmaceuticals, which is jointly developing a drug with Dyax Corp to treat an eye indication.
Mergers & acquisitions
Sanofi (France)
MORE ON THIS TOPIC
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Mergers & acquisitions
Chiesi, Arbor Weave $2.1B Rare Disease Pact
October 6, 2025
 · 
1 min read
 · 
Tristan Manalac
Group of blue paper boats following on red on yellow background, mass manipulation
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
 · 
3 min read
 · 
Annalee Armstrong
Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.
Mergers & acquisitions
Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together
October 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
M&A Picks Up, Walmsley Moves On, Pfizer’s MFN Deal and Hope for Huntington’s
October 1, 2025
 · 
2 min read
 · 
Heather McKenzie